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The Value of Procalcitonin and the SAPS II and APACHE III 
Scores in the Differentiation of Infectious and Non-infectious 
Fever in the ICU: A Prospective, Cohort Study  
Early and accurate differentiation between infectious and non-infectious fever is vitally 
important in the intensive care unit (ICU). In the present study, patients admitted to the 
medical ICU were screened daily from August 2008 to February 2009. Within 24 hr after 
the development of fever (>38.3°C), serum was collected for the measurement of the 
procalcitonin (PCT) and high mobility group B 1 levels. Simplified Acute Physiology Score 
(SAPS) II and Acute Physiology And Chronic Health Evaluation (APACHE) III scores were also 
analyzed. Sixty-three patients developed fever among 448 consecutive patients (14.1%). 
Fever was caused by either infectious (84.1%) or non-infectious processes (15.9%). Patients 
with fever due to infectious causes showed higher values of serum PCT (7.8±10.2 vs 0.5±0.2 
ng/mL, P=0.026), SAPS II (12.0±3.8 vs 7.6±2.7, P=0.006), and APACHE III (48±20 vs 
28.7±13.3, P=0.039) than those with non-infectious fever. In receiver operating 
characteristic curve analysis, the area under the curve was 0.726 (95% CI; 0.587-0.865) for 
PCT, 0.759 (95% CI; 0.597-0.922) for SAPS II, and 0.715 (95% CI; 0.550-0.880) for APACHE 
III. Serum PCT, SAPS II, and APACHE III are useful in the differentiation between infectious 
and non-infectious fever in the ICU. 
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Fever, defined as an increase in body temperature above 38.3°C 
(100.4°F), occurs in approximately one-third of all medical pa-
tients during their hospital stay (1). Intensive care unit (ICU) 
patients frequently develop fevers which can originate from in-
fectious or non-infectious causes (2-4). The main causes of non-
infectious fever include myocardial infarction, pulmonary em-
bolism, deep vein thrombosis, cerebral infarction, hemorrhage, 
atelectasis, pancreatitis, acalculus cholecystitis, drug fever, and 
postoperative fever. On the other hand, major causes of infec-
tious fever in the ICU include ventilator-associated pneumonia, 
sinusitis, catheter-related infections, nosocomial diarrhea, and 
wound infections (5). 
  Fever has multiple clinical effects: increased energy expendi-
ture, myocardial, and respiratory demands, as well as discomfort 
and worse central nervous system (CNS) injury. On the other 
hand, fever is regarded as a beneficial host immune response 
to infection (6). Fever frequently leads to a series of diagnostic 
work-ups which significantly increase medical costs and expose 
the patient to the risk of invasive procedures. Empirical treatment 
of fever, which frequently follows diagnostic work-ups, may result 
in the inappropriate use of antibiotics and an increase in antibi-
otic-resistant pathogens. As such, early and accurate differenti-
ation between infectious and non-infectious fever is very im-
portant. 
  Several biologic markers have been tested for their ability to 
discriminate between infectious and noninfectious fever, in-
cluding serum procalcitonin (PCT), C-reactive protein (CRP), 
tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) (7). 
However, none of these markers have been proven to have 
enough power to be useful in clinical practice.
  The high mobility group box-1 (HMGB1) protein is a 30 kDa 
nonhistone nuclear DNA binding protein that has been shown 
to have an extracellular role in inflammation, cell differentiation, 
adherence, and motility (8). HMGB1 has also been proposed as 
one of the mediators of sepsis (9, 10). Therefore, HMGB1 may 
be useful as a differential marker for the evaluation of fever in 
ICU patients (11). However, serum HMGB1 has not yet been 
evaluated for this purpose. 
  Febrile patients by infectious cause of fever have more chance 
to develop organ dysfunction and subsequent high score in 
acute physiology and chronic health evaluation (APACHE) III 
system and are associated with increased mortality (12). How-Jeon EJ, et al.  •  Differentiation of Infectious and Noninfectious Fever in the ICU
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ever, APACHE III score and other disease severity score, such as 
simplified acute physiology score (SAPS) II have not specifically 
evaluated for the purpose of discrimination between infectious 
and non-infectious fever in the ICU. 
  In the present study, we evaluated the value of serum PCT, 
HMGB1, SAPS II, and APACHE III scores in the differentiation 
between infectious and non-infectious fever in ICU patients. 
MATERIALS AND METHODS
Study population 
A prospective cohort study was conducted at the 21-bed medi-
cal intensive care unit (MICU) of Chung-Ang University Hospi-
tal, Seoul, Korea, from August 2008 to February 2009. This study 
was approved by the IRB of Chung-Ang University Hospital and 
the approval number was C2008015(118). Informed consent 
was obtained from the family members of the patients.
  During the 7-month period (August 2008 to February 2009), 
448 patients were consecutively admitted to the MICU. Fever 
developed in 63 of these patients (14.1%). Thirty-five patients 
were men and 28 were women, and the mean age was 65.2±12.4 
yr. Fever developed within three days of admission in 46 of the 
63 patients. The mean duration of ICU stay was 25.8±20.2 days, 
and the mean duration of fever was 3.0±2.4 days. The SAPS II 
and APACHE III scores were 11.2±3.8 and 45.3±19.5, respec-
tively (Table 1).
Measurement of clinical and laboratory parameters
Body temperature was measured using the axillary method with 
an electronic thermometer (Thermoval classic, PAUL HART-
MANN AG, German). We defined ICU fever as a body tempera-
ture above 38.3°C that developed 48 hr after ICU admission. 
Within 24 hr after the development of fever, serum samples were 
collected and stored at -70°C and serum PCT and HMGB1 levels 
were measured later with duplication. A fluorescent enzyme 
immunoassay (FEIA) (VIDAS BRAHMS PCT, France) was used 
to measure PCT levels. Serum HMGB1 levels were evaluated 
with an enzyme-linked immunosorbent assay (HMGB1 ELISA 
kit, Shino-Test Co, Japan). Clinical parameters, including demo-
graphic data, underlying diseases, duration of ICU stay, causes 
of fever, SAPS II, APACHE III scores, and mortality rate were also 
analyzed. 
Diagnostic criteria for the cause of fever
Pneumonia was defined as a constellation of symptoms and 
signs in combination with at least a newly developed infiltrate 
upon chest radiography. Urinary tract infection (UTI) was de-
fined as pathogenic microorganisms detected in the urine at 
more than 100,000 organisms/mL (13). Sepsis was defined as 
systemic inflammatory response syndrome (SIRS) with a proven 
or suspected microbial etiology (14). Phlebitis was defined as 
the clinical findings of pain, tenderness, induration, and/or ery-
thema in a superficial vein due to inflammation, infection, and/
or thrombosis (15). Post-operative fever was defined as non-in-
fectious fever occurring within the first 4 post-operative days, 
based on a modification of the description by Clarke et al. (16). 
Drug fever was defined as a disorder characterized by fever co-
inciding with the administration of a drug and disappearing af-
ter the discontinuation of the drug, when no other cause for the 
fever was evident after a careful physical examination and labo-
ratory investigation. Fevers were labeled as unknown cause when 
routine medical and laboratory examination did not reveal the 
origin of fever. 
Causes of fever
Most fevers were due to infectious causes (53 cases, 84.1%). Pneu-
monia (27 cases, 42.9%) was the most common cause of infec-
tious fever. Other causes of infectious fever were sepsis, postop-
erative wound infection, and urinary tract infection. Causes of 
non-infectious fever (10 cases, 15.9%) included drug fever, gas-
Table 1. Characteristics of febrile patients with infectious or non-infectious causes
Characteristics Total Infectious cause Non-infectious cause P value
Number 63 53 10
Age (yr) 65.2±12.4 66.0±11.9 60.1±13.7 0.185
Sex (Male:Female) 35:28 29:24 6:4 0.760
Admission route (community:general ward) 38:25 32:21 6:4 0.623
Duration of ICU admission (days)   25.8±20.2 28.0±22.3 19.0±15.2 0.114
Duration of fever (days)   3.0±2.4 2.9±2.2 3.6±3.0 0.714
Onset of fever since admission (days)   8.4±7.1 9.2±8.4 4.4±2.9 0.154
Fever ≤3 days 45 (71.4%) 36 (67.9%) 9 (90.0%) 0.150
Procalcitonin (ng/mL)   6.6±9.1   7.8±10.2 0.5±0.2 0.026*
HMGB1 (ng/mL)   13.3±10.1 13.1±10.4 16.4±10.5 0.522
SAPS II (points) 11.2±3.8  12±3.8 7.6±2.7 0.006*
APACHE III (points)   45.3±19.5 48±20 28.7±13.3 0.039*
Mortality rate (%) 12.7 (n=8) 11.3 (n=6) 20 (n=2) 0.333
*P<0.05.
HMGB1, high mobility group B-1; SAPS II, a severity of disease classification system II; APACHE III, Acute Physiology And Chronic Health Evaluation III score.Jeon EJ, et al.  •  Differentiation of Infectious and Noninfectious Fever in the ICU
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trointestinal bleeding, and postoperative fever (Table 2). 
Statistical analysis
Statistical analyses were performed using the Statistical Pack-
age for the Social Sciences version 17.0 (SPSS, Inc., Chicago, IL, 
USA). Continuous variables were compared using the Student t 
test for normally distributed variables and the Mann-Whitney 
U test was used for non-normally distributed variables. P values 
of less than 0.05 were considered significant. The ability of each 
parameter to discriminate between infectious and non-infec-
tious fever was investigated using a receiver operating charac-
teristic (ROC) analysis.
RESULTS 
There were no significant differences in age (P=0.19), gender 
(P=0.76), serum HMGB1 (P=0.52), and mortality rate (P=0.33) 
between patients with infectious and non-infectious fever (Table 
1). Febrile patients with infectious causes had higher levels of 
serum PCT than those with non-infectious causes (7.8±10.2 vs 
0.5±0.2 ng/mL, P=0.026). In addition, infectious fever was asso-
ciated with higher SAPS II and APACHE III scores (12±3.8 vs 
7.6±2.7, P=0.006; 48±20 vs 28.7±13.3, P=0.039) (Table 1). 
  The Receiver Operating Characteristic (ROC) curve analysis 
revealed that the diagnostic performance of PCT and the SAPS 
II and APACHE III scores for infectious and non-infectious fever 
was in the good range, and the area under the curve (AUC) was 
0.726 (95% CI; 0.587-0.865) for PCT, 0.759 (95% CI; 0.597-0.922) 
for the SAPS II score, and 0.715 (95% CI; 0.550-0.880) for the 
APACHE III score (Fig. 1). The optimum cutoff value for distin-
guishing between infectious and non-infectious fever was 0.68 
ng/mL for PCT (sensitivity, 67.6%; specificity, 80.0%), 8.5 points 
for the SAPS II score (sensitivity, 78.4%; specificity, 70.0%), and 
31.5 points for the APACHE III score (sensitivity, 64.9%; speci-
Table 2. Causes of fever in the ICU
Infectious cause (n=53, 84.1%) Non-infectious cause (n=10, 15.9%)
Pneumonia  27 (42.9%) Drug fever 2 (3.2%)
Sepsis   9 (14.3%) GI bleeding 2 (3.2%)
Post op. wound inf. 6 (9.5%) Post-operative fever 1 (1.6%)
UTI  4 (6.3%) Pancreatitis 1 (1.6%)
Liver abscess 2 (3.2%) Lymphoma 1 (1.6%)
IV cath. Inf. 1 (1.6%) SDH  1 (1.6%)
Others 4 (6.3%) Atelectasis 1 (1.6%)
Unknown cause 1 (1.6%)
Post op. wound inf., postoperative wound infection; UTI, urinary tract infection; IV 
cath. Inf., intravenous catheter infection; ‘Others’ of infectious cause were meningitis, 
brain abscess, cholangitis and peritonitis, respectively; GI bleeding, gastrointestinal 
bleeding; SDH, subdural hemorrhage.
Table 3. Cut-off values of procalcitonin, HMGB1, and SAPS and APACHE III scores
Test result variables Cut–off value Sensitivity Specificity
Procalcitonin (ng/mL) 0.68 0.676 0.800
HMGB1 (point) 13.785 0.351 0.600
SAPS II (points) 8.5 0.784 0.700
APACHE III (points) 31.5 0.649 0.700
HMGB1, high mobility group B-1; SAPS II, a severity of disease classification system 





















Fig. 1. ROC curve for the prediction of infectious and non-infectious fever. HMGB1, 
high mobility group B 1; SAPS, simplified acute physiology score; APACHE, acute 
physiology and chronic health evaluation III. The area under the curve was 0.726 
(95% CI; 0.587-0.865) for PCT, 0.759 (95% CI; 0.597-0.922) for the SAPS II score, 
and 0.715 (95% CI; 0.550-0.880) for the APACHE III score. 


























Fig. 2. Receiver operating characteristic (ROC) curve for the prediction of infectious 
and non-infectious fever with the combination of PCT, SAPS II and APACHE III scores. 
ProSAPS, combination of PCT and SAPS II score; proAPA, combination of PCT and 
APACHE III score; SAPSAPA, combination of SAPS II score and APACHE III score; 
proSAPSAPA, combination of PCT, SAPS II score, and APACHE III score. The area 
under the curve was 0.849 (95% CI; 0.746-0.952) for PCT+SAPS II, 0.830 (95% CI; 
0.710-0.950) for PCT+APACHE III, 0.862 (95% CI; 0.762-0.962) for SAPS II+APACHE 
III, and 0.917 (95% CI; 0.848-0.986) for PCT+SAPS II+APACHE III. 
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ficity, 70.0%) (Table 3), respectively. The combination of PCT, 
SAPS II and APACHE III scores increased the AUC and diagnos-
tic accuracy (Fig. 2). When we set the cut off value of PCT to 0.68 
ng/mL, SAPS II to 8.5 points, and APACHE III to 31.5 points, the 
combination of all three parameters showed 100% of sensitivity, 
25% of specificity, 43% of positive predictive value, and 100% of 
negative predictive value for the differentiation between infec-
tious and non-infectious fever.  
DISCUSSION 
In the present study, we evaluated biologic markers, including 
serum PCT and HMGB1, and disease severity scores, such as 
SAPS II and APACHE III, in the differentiation of infectious and 
non-infectious fever in the ICU. In accordance with the guide-
lines of the Society of Critical Care Medicine and the Infectious 
Disease Society of America, we defined an ICU fever as a tem-
perature equal to or above 38.3°C in patients who stayed in the 
ICU for at least 48 hr (3). 
  In the present study, fever developed in 63 patients among 
448 consecutive patients admitted to the ICU (14.1%), which 
was far less as compared to other report (2). The low prevalence 
of ICU fever in our study might be explained by the fact that we 
evaluated patients admitted to the medical ICU and excluded 
patients in the surgical ICU, where fever can be due to many 
causes, such as wound infection, transfusion reaction, and post-
operative fever. Also, our ICU contains a coronary care unit (CCU), 
and these patients usually have a low risk for infectious disease. 
In addition, we used the axillary method to check body temper-
ature, and this method usually results in lower temperature com-
pared to other methods (17, 18).  
  ICU patients frequently have multiple infectious and nonin-
fectious causes of fever, necessitating a systematic and compre-
hensive diagnostic approach. The most common infection re-
ported in ICU patients is pneumonia, followed by sinusitis, blood 
stream infection, and catheter-related infection (2, 4, 19). As was 
reported in our previous study, infectious causes of fever (84.1%) 
predominated, and pneumonia was the most common cause 
of infection (42.9%) in the present study (20). While infections 
are important causes of fever in the ICU, many noninfectious 
inflammatory conditions result in tissue injury, inflammation, 
and a febrile reaction. Noninfectious disorders that should be 
considered in ICU patients are post-operative fever, transfusion 
reaction, drug fever, and cerebral infarction (15). In the present 
study, causes of non-infectious fever (10 cases, 15.9%) were drug 
fever, gastrointestinal bleeding, and postoperative fever (Table 2). 
  It is well known that early recognition, together with prompt 
and appropriate treatment of infections, can significantly reduce 
mortality in critically ill patients (2). The dilemma with ICU fever 
is to exclude noninfectious causes as soon as possible and then 
to locate the site of infection and determine the likely pathogens. 
To date, no single clinical or biological indicator has gained unan-
imous acceptance in the differentiation between infectious and 
noninfectious fever in the ICU. 
  CRP and PCT have been used as objective markers of bacte-
rial infection. Although CRP is a more sensitive marker of sepsis 
than either body temperature or white blood cell count, it lacks 
specificity (21). PCT, a propeptide of calcitonin, is found to be an 
earlier marker of septic shock than CRP and it correlates more 
closely to severity of disease (22). Pleural effusion PCT was high-
er in bacterial pneumonia than in non-bacterial infection (23). 
However, there is a debate for the utility of PCT in distinguishing 
infection from other causes of systemic inflammatory response 
syndrome (SIRS) in older patients (24). In the present study, we 
were able to confirm that serum PCT levels were significantly 
high in patients with infectious fever (Table 1). Manufacturer’s 
instruction recommends interpreting PCT results with the five 
categories indicating healthy condition, local infection, sepsis, 
severe sepsis, and septic shock. However, in the present study, 
the mean value of PCT in 9 patients with sepsis (6.9 ng/mL) was 
not different from that of other patients with local infection (7.8 
ng/mL). 
  We also evaluated serum HMGB1 for this purpose because 
there is abundant evidence supporting the role of HMGB1 as 
an inflammatory mediator, especially in sepsis (9, 10). To our 
disappointment, serum HMGB1 proved not to be useful as a 
tool in the differentiation between infectious and non-infectious 
fever (Table 1). In the present study, disease severity scores, in-
cluding the SAPS II and APACHE III scores, were different be-
tween infectious and noninfectious fever (Table 3) (Fig. 1). The 
overlap between the two groups was too large to be used in the 
differentiation of infectious and non-infectious fever. However, 
combination of each parameter and especially combination of 
all three parameters, PCT, SAPS II, and APACHE III score in-
creased AUC and diagnostic accuracy for the differentiation (Fig. 
2). Because there is no single clinical or biological indicator that 
gained unequivocal acceptance in the differentiation between 
infectious and noninfectious fever in the ICU, the combined 
analysis of all three parameters might be a practical alternative 
for this purpose.   
  Our study has a few limitations. First, we performed the study 
at only one hospital and evaluated only patients admitted to the 
medical ICU. We were able to identify candidate parameters for 
the differentiation of infectious and noninfectious fever (serum 
PCT, SAPS II, and APACHE III scores). However, there is a limi-
tation in the diagnostic accuracy of three parameters. Despite 
these limitations, our study may be the rare, prospective study 
in Korean population to evaluate parameters for the differentia-
tion between infectious and noninfectious fever in the ICU. 
  In conclusion, serum PCT levels, SAPS II and APACHE III scores 
demonstrated significant differences between patients with in-
fectious and non-infectious fever and combined analysis of all Jeon EJ, et al.  •  Differentiation of Infectious and Noninfectious Fever in the ICU
http://jkms.org   1637 DOI: 10.3346/jkms.2010.25.11.1633
three parameters increased diagnostic accuracy. 
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